ACE Inhibitors
Use
- Hypertension
- CCF
- Post infarction to prevent deleterious cardiac remodelling
Presentation
Tablets
Dose
Ramipril 2.5mg BD
Onset
2 hrs
MoA (Mechanism)
- Inhibits AI \( \xrightarrow{\text{ACE }} \) AII (ramiprilat binds reversibly to ACE so it can’t act & dissoc. very slowly → long t ½)
- ∴ formation of AII
- ∴ cardinal effects
- Vasodilation (arterial & venous)
- ↓BP, preL, afteRL
- ↓blood volume
- ↓symp activity
- Inhibit cardiac & vascular hypertrophy
PD
CVS – ↓BP & circulating volume
- ↑[kallikreins] which are also metabolised by ACE compound the VD
CNS – ↓symp outflow
PK
A
60% OBA
D
PPB 70%
M
Hepatic metabolism to RAMIPRILAT
E
t ½ B 20hrs
Metabolites & active drug excreted renally (60%) & faecally (40%)
Adverse Effects
- Angioedema
- Dry cough 2° ↑[bradykinin]
- Hyperkalaemia
- Headache
- Dizziness
- Fatigue
- Renal impairment
- C/I in pregnancy
- C/I in bilateral renal a. stenosis
- AII constricts eff > aff arteriole
- ∴ helps maintain glomerular filtration → removing this can cause an abrupt ↓filtration
- Big problem with bilateral renal a. stenosis